Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | SLXN | Ordinary Shares | 1.99M | Aug 15, 2024 | By Guangzhou Sino-Israel Biotech Fund | F1 |
Id | Content |
---|---|
F1 | The Reporting Person possesses shared voting and investment authority with respect to the shares reported in this line by virtue of his serving as Chief Medical Officer of Guangzhou Sino-Israel Biotech Fund ("GIBF"). The equity interests of GIBF are held by various individuals and entities. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his indirect pecuniary interest therein. |